237 related articles for article (PubMed ID: 28562153)
41. Vdelta1 and Vdelta2 gammadelta T cells express distinct surface markers and might be developmentally distinct lineages.
De Rosa SC; Mitra DK; Watanabe N; Herzenberg LA; Herzenberg LA; Roederer M
J Leukoc Biol; 2001 Oct; 70(4):518-26. PubMed ID: 11590187
[TBL] [Abstract][Full Text] [Related]
42. Protective role of the inflammatory CCR2/CCL2 chemokine pathway through recruitment of type 1 cytotoxic γδ T lymphocytes to tumor beds.
Lança T; Costa MF; Gonçalves-Sousa N; Rei M; Grosso AR; Penido C; Silva-Santos B
J Immunol; 2013 Jun; 190(12):6673-80. PubMed ID: 23686489
[TBL] [Abstract][Full Text] [Related]
43. Distinct metabolic programs established in the thymus control effector functions of γδ T cell subsets in tumor microenvironments.
Lopes N; McIntyre C; Martin S; Raverdeau M; Sumaria N; Kohlgruber AC; Fiala GJ; Agudelo LZ; Dyck L; Kane H; Douglas A; Cunningham S; Prendeville H; Loftus R; Carmody C; Pierre P; Kellis M; Brenner M; Argüello RJ; Silva-Santos B; Pennington DJ; Lynch L
Nat Immunol; 2021 Feb; 22(2):179-192. PubMed ID: 33462452
[TBL] [Abstract][Full Text] [Related]
44. Numerical and functional alterations of circulating gammadelta T lymphocytes in aged people and centenarians.
Argentati K; Re F; Donnini A; Tucci MG; Franceschi C; Bartozzi B; Bernardini G; Provinciali M
J Leukoc Biol; 2002 Jul; 72(1):65-71. PubMed ID: 12101264
[TBL] [Abstract][Full Text] [Related]
45. Expansions of tumor-reactive Vdelta1 gamma-delta T cells in newly diagnosed patients with chronic myeloid leukemia.
Knight A; Piskacek M; Jurajda M; Prochazkova J; Racil Z; Zackova D; Mayer J
Cancer Immunol Immunother; 2023 May; 72(5):1209-1224. PubMed ID: 36376516
[TBL] [Abstract][Full Text] [Related]
46. COVID-19 vaccination influences subtypes of γδ-T cells during pregnancy.
Wang L; Li J; Jiang S; Li Y; Guo R; Chen Y; Chen Y; Yu H; Qiao Q; Zhan M; Yin Z; Xiang Z; Xu C; Xu Y
Front Immunol; 2022; 13():900556. PubMed ID: 36311780
[TBL] [Abstract][Full Text] [Related]
47. Association between peripheral γδ T-cell profile and disease progression in individuals infected with HIV-1 or HIV-2 in West Africa.
Zheng NN; McElrath MJ; Sow PS; Mesher A; Hawes SE; Stern J; Gottlieb GS; De Rosa SC; Kiviat NB
J Acquir Immune Defic Syndr; 2011 Jun; 57(2):92-100. PubMed ID: 21423026
[TBL] [Abstract][Full Text] [Related]
48. The emerging Protumor role of γδ T lymphocytes: implications for cancer immunotherapy.
Rei M; Pennington DJ; Silva-Santos B
Cancer Res; 2015 Mar; 75(5):798-802. PubMed ID: 25660949
[TBL] [Abstract][Full Text] [Related]
49. Dysregulated CD25 and Cytokine Expression by γδ T Cells of Systemic Sclerosis Patients Stimulated With Cardiolipin and Zoledronate.
Migalovich Sheikhet H; Villacorta Hidalgo J; Fisch P; Balbir-Gurman A; Braun-Moscovici Y; Bank I
Front Immunol; 2018; 9():753. PubMed ID: 29706966
[TBL] [Abstract][Full Text] [Related]
50. Toll-like receptor expression and function in subsets of human gammadelta T lymphocytes.
Pietschmann K; Beetz S; Welte S; Martens I; Gruen J; Oberg HH; Wesch D; Kabelitz D
Scand J Immunol; 2009 Sep; 70(3):245-55. PubMed ID: 19703014
[TBL] [Abstract][Full Text] [Related]
51. Tissue-Resident Memory T Cells in Cancer Immunosurveillance.
Park SL; Gebhardt T; Mackay LK
Trends Immunol; 2019 Aug; 40(8):735-747. PubMed ID: 31255505
[TBL] [Abstract][Full Text] [Related]
52. Myeloid-Derived Suppressor Cells Specifically Suppress IFN-γ Production and Antitumor Cytotoxic Activity of Vδ2 T Cells.
Sacchi A; Tumino N; Sabatini A; Cimini E; Casetti R; Bordoni V; Grassi G; Agrati C
Front Immunol; 2018; 9():1271. PubMed ID: 29928279
[TBL] [Abstract][Full Text] [Related]
53. Single-Cell RNAseq Profiling of Human γδ T Lymphocytes in Virus-Related Cancers and COVID-19 Disease.
Cerapio JP; Perrier M; Pont F; Tosolini M; Laurent C; Bertani S; Fournie JJ
Viruses; 2021 Nov; 13(11):. PubMed ID: 34835019
[TBL] [Abstract][Full Text] [Related]
54. Chemotherapy accelerates immune-senescence and functional impairments of Vδ2
Bruni E; Cazzetta V; Donadon M; Cimino M; Torzilli G; Spata G; Leonardi G; Dieli F; Mikulak J; Mavilio D
J Immunother Cancer; 2019 Dec; 7(1):347. PubMed ID: 31829255
[TBL] [Abstract][Full Text] [Related]
55. Chimeric Antigen Receptor-Engineered Human Gamma Delta T Cells: Enhanced Cytotoxicity with Retention of Cross Presentation.
Capsomidis A; Benthall G; Van Acker HH; Fisher J; Kramer AM; Abeln Z; Majani Y; Gileadi T; Wallace R; Gustafsson K; Flutter B; Anderson J
Mol Ther; 2018 Feb; 26(2):354-365. PubMed ID: 29310916
[TBL] [Abstract][Full Text] [Related]
56. Zoledronate-activated Vγ9γδ T cell-based immunotherapy is feasible and restores the impairment of γδ T cells in patients with solid tumors.
Noguchi A; Kaneko T; Kamigaki T; Fujimoto K; Ozawa M; Saito M; Ariyoshi N; Goto S
Cytotherapy; 2011 Jan; 13(1):92-7. PubMed ID: 20831354
[TBL] [Abstract][Full Text] [Related]
57. Primary and Chronic HIV Infection Differently Modulates Mucosal Vδ1 and Vδ2 T-Cells Differentiation Profile and Effector Functions.
Cimini E; Agrati C; D'Offizi G; Vlassi C; Casetti R; Sacchi A; Lionetti R; Bordoni V; Tumino N; Scognamiglio P; Martini F
PLoS One; 2015; 10(6):e0129771. PubMed ID: 26086523
[TBL] [Abstract][Full Text] [Related]
58. Phenotypic characterization and prognostic impact of circulating γδ and αβ T-cells in metastatic malignant melanoma.
Wistuba-Hamprecht K; Di Benedetto S; Schilling B; Sucker A; Schadendorf D; Garbe C; Weide B; Pawelec G
Int J Cancer; 2016 Feb; 138(3):698-704. PubMed ID: 26383054
[TBL] [Abstract][Full Text] [Related]
59. Cancer immunotherapy with γδ T cells: many paths ahead of us.
Kabelitz D; Serrano R; Kouakanou L; Peters C; Kalyan S
Cell Mol Immunol; 2020 Sep; 17(9):925-939. PubMed ID: 32699351
[TBL] [Abstract][Full Text] [Related]
60. Tumor-infiltrating IL-17-producing gammadelta T cells support the progression of tumor by promoting angiogenesis.
Wakita D; Sumida K; Iwakura Y; Nishikawa H; Ohkuri T; Chamoto K; Kitamura H; Nishimura T
Eur J Immunol; 2010 Jul; 40(7):1927-37. PubMed ID: 20397212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]